Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

(MedPage Today) -- The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study.
Among over 19,000 matched...